Explore Our Technology
Learn more about the exciting field of intratumoral immunotherapy and OncoSec’s role as a key leader in this emerging space.
OncoSec to Present Updated Clinical and Immune Biomarker Data from its Monotherapy and Combination Therapy studies with ImmunoPulse® IL-12 at the 9th World Congress of Melanoma – A Joint Meeting with the Society for Melanoma Research
2nd Annual Biomarkers & Precision Medicine USA Congress | October 9-11, 2017
San Diego, CA
9th Annual World Congress of Melanoma – A Joint Meeting with the Society of Melanoma Research| October 18-21, 2017